Julen Rodríguez-Castejón

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Top Venues

Drug delivery and translational research

Integrated pharmacy research & practice

Nanomaterials (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Julen Rodríguez-Castejón, Marina Beraza-Millor, María Angeles Solinís Aspiazu, Alicia Rodríguez-Gascón, Ana Del Pozo-Rodríguez
Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review. Drug delivery and translational research (2024)
Xabier Aizpurua-Arruti, Shalom Charlie I Benrimoj, Estibaliz Goyenechea, Arantxazu Isla, Ainhoa Oñatibia-Astibia, Amaia Malet-Larrea, Miguel Angel Gastelurrutia, Olatz Cuevas, Julen Rodríguez-Castejón, Saioa Domingo-Echaburu, María Angeles Solinís Aspiazu, Montserrat Garcia, Ana Del Pozo-Rodríguez
Outcomes of Community Pharmacy Interventions on Patients with Medicines Under Additional Monitoring. Integrated pharmacy research & practice 13 (2024)
Xabier Aizpurua-Arruti, Shalom Charlie I Benrimoj, Estibaliz Goyenechea, Arantxazu Isla, Ainhoa Oñatibia-Astibia, Amaia Malet-Larrea, Miguel Angel Gastelurrutia, Olatz Cuevas, Julen Rodríguez-Castejón, Saioa Domingo-Echaburu, María Angeles Solinís Aspiazu, Montserrat Garcia, Ana Del Pozo-Rodríguez
Outcomes of Community Pharmacy Interventions on Patients with Medicines Under Additional Monitoring. Integrated pharmacy research & practice 13 (2024)
Julen Rodríguez-Castejón, Marina Beraza-Millor, María Angeles Solinís Aspiazu, Alicia Rodríguez-Gascón, Ana Del Pozo-Rodríguez
Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review. Drug delivery and translational research (2024)
Marina Beraza-Millor, Julen Rodríguez-Castejón, Jonatan Miranda, Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón, María Angeles Solinís Aspiazu
Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease. Pharmaceutics 15 (7) (2023)
Julen Rodríguez-Castejón, Itziar Gómez-Aguado, Marina Beraza-Millor, María Angeles Solinís Aspiazu, Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón
Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease. Nanomaterials (Basel, Switzerland) 12 (14) (2022)
Julen Rodríguez-Castejón, Ana Alarcia-Lacalle, Itziar Gómez-Aguado, Mónica Vicente-Pascual, María Angeles Solinís Aspiazu, Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón
α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice. Pharmaceutics 13 (6) (2021)
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, Mónica Vicente-Pascual, Alicia Rodríguez-Gascón, Sara Garelli, Luigi Battaglia, Ana Del Pozo-Rodríguez, María Angeles Solinís Aspiazu
mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation. Pharmaceutics 13 (9) (2021)
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, Alicia Rodríguez-Gascón, Ana Del Pozo-Rodríguez, María Angeles Solinís Aspiazu
Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA. Molecules (Basel, Switzerland) 25 (24) (2020)
Mónica Vicente-Pascual, Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Alicia Rodríguez-Gascón, Elisabetta Muntoni, Luigi Battaglia, Ana Del Pozo-Rodríguez, María Angeles Solinís Aspiazu
Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production. Pharmaceutics 12 (6) (2020)